Literature DB >> 22179408

Endoscopy-based decision is sufficient for predicting completeness in lateral resection margin in colon endoscopic submucosal dissection.

Ki Joo Kang1, Dong Uk Kim, Beom Jin Kim, Young-Ho Kim, Poong-Lyul Rhee, Jae J Kim, Jong Chul Rhee, Dong Kyung Chang.   

Abstract

BACKGROUND AND AIMS: Our aim was to investigate the incidence of tumor recurrence in cases in which there was a discrepancy in the diagnosis of complete resection by pathologists and colonoscopists, especially in the lateral resection margin.
METHODS: We reviewed 245 patients with colorectal tumors that were treated by endoscopic submucosal dissection (ESD) between March 2006 and June 2011. We evaluated the recurrence rate in cases judged as pathologically incomplete resection despite endoscopically complete resection.
RESULTS: Of the 24 cases with tumor cells on the lateral resection margin, the histologies of the colorectal tumors were found to be tubular adenoma (TA) with low-grade dysplasia (n = 19), TA with high-grade dysplasia (n = 3) and differentiated adenocarcinoma (n = 2). No tumor recurrence was observed in 22 patients after ESD. Four patients did not receive surveillance colonoscopy. The median tumor size was 28 mm (12-35) and the median follow-up period was 19 months (5-42).
CONCLUSIONS: This retrospective analysis was limited by a short follow-up period. However, surveillance colonoscopy could be attempted without additional ESD in those cases in which incomplete resection on the lateral margin was judged pathologically, if endoscopic complete resection was grossly achieved.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22179408     DOI: 10.1159/000334713

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  1 in total

1.  Indications for and technical aspects of colorectal endoscopic submucosal dissection.

Authors:  Yutaka Saito; Yosuke Otake; Taku Sakamoto; Takeshi Nakajima; Masayoshi Yamada; Shin Haruyama; Eriko So; Seiichiro Abe; Takahisa Matsuda
Journal:  Gut Liver       Date:  2013-02-07       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.